Exacerbation of asthma in children and exposure to environmental tobacco smoke : a detailed review of the epidemiological evidence / Peter N. Lee and Barbara A. Forey.

Format:

Book

Author/Creator:

Lee, Peter N., 1943-

Contributor:

Forey, Barbara.

Language:

English

Subjects (All):

Asthma in children--Epidemiology.

Asthma in children.

Asthma in children--Etiology.

Physical Description:

1 online resource (126 p.)

Edition:

1st ed.

Place of Publication:

New York : Nova Science, 2009.

Language Note:

English

Summary:

The literature searches identified 60 publications which together described the results of a total of 47 relevant epidemiological studies in children. Eighteen of the studies were conducted in the USA, four in Canada, 13 in Europe (in a total of 10 countries), five in Turkey or the Middle East, three in India or the Far East, three in Africa and one in New Zealand. Seven references were published as abstracts. A further 17 publications described studies that seemed possibly relevant, but did not meet the inclusion criteria. The reasons for rejection included no actual data collected on ETS exposure, the study only reporting on whether tobacco smoke brought on wheezing (Speer, 1968), no results reported relating ETS exposure to aggravation of asthma (Wood et al., 1993; Huss et al., 1994; Chadwick, 1996; Gilliland et al., 2001; Morgan et al., 2004), results not reported separately for children (Tarlo et al., 2000; Bayona et al., 2002), results not reported separately for asthmatics (Lebowitz, 1984a; Lebowitz, 1984b; Toyoshima et al., 1987; Strachan et al., 1990; Agudo et al., 1994; Henderson et al., 1995; Fielder et al., 1999; Willers et al., 2000) and endpoint (respiratory illness) too broad (Gilliland et al., 2003). A further study (Bener et al., 1991) was rejected as the data presented seemed totally implausible, with 85% of a sample of schoolchildren reported to have asthma and the odds of having a frequent attack 34 times higher if one of the parents smoked. The studies are described individually in sections 1.2 (USA), 1.3 (Canada), 1.4 (Europe), 1.5 (Asia) and 1.6 (Other). Section 1.7 then summarizes various relevant aspects of the studies considered and section 2 brings together the findings by type of endpoint.

Contents:

Intro

EXACERBATION OF ASTHMA IN CHILDREN AND EXPOSURE TO ENVIRONMENTAL TOBACCO SMOKE - A DETAILED REVIEW OF THE EPIDEMIOLOGICAL EVIDENCE

CONTENTS

LIST OF TABLES

ABBREVIATIONS

PREFACE

1. THE STUDIES

1.1. INTRODUCTION

1.2. DESCRIPTION OF THE STUDIES - USA

The Minnesota Study

The Michigan and Massachusetts Study

The First New York Study

The Boston Study

The Second New York Study

National Health Interview Survey

The Portland Study

The Baltimore Study

The Seattle Study

The Davis Study

The Chicago Study

The New Orleans Study

The First California Study

The Second California Study

NHANES III

The Baltimore and Washington DC Study

The Denver Study

The Third New York Study

1.3. DESCRIPTION OF THE STUDIES - CANADA

The Vancouver Study

The Toronto Study

The Edmonton Study

The Nine Region Study

1.4. DESCRIPTION OF THE STUDIES - EUROPE

England: The Sheffield Study

England: The North East England Study

Finland: The Kuopio Study

France: The Marseilles Study

France: The Nationwide Study

Germany: The Freiburg Study

Germany: The Lower Saxony Study

Italy: The Viterbo Province Study

Netherlands: The Zwolle Study

Portugal: The Lisbon Study

Scotland: The Tayside and Fife Study

Spain: The San Sebastian Study

Sweden: The Stockholm Study

1.5. DESCRIPTION OF THE STUDIES - ASIA(INCLUDING TURKEY)

China: The Anqing Study

India: The New Delhi Study

Lebanon: The Tripoli Study

Saudi Arabia: The Al-Majmaah Study

Taiwan Study

Turkey: The First Istanbul Study

Turkey: The Second Istanbul Study

Turkey: The Diyarbakir Study

1.6. DESCRIPTION OF THE STUDIES - OTHER AREAS

Kenya: The Nairobi Study

New Zealand: The Christchurch Study

Nigeria: The Ibadan Study

South Africa: The Cape Town Study.

1.7. SUMMARY OF THE STUDIES

2. RESULTS

2.1. ASTHMA EXACERBATION AND SEVERITY

Hospitalisation: Table 5

Emergency Room Visits: Table 6

Restricted activity: Table 7

Acute and Non-Acute Asthma: Table 8

Asthma Medication: Table 9

Health Contacts for Asthma: Table 10

Asthma Severity: Table 11

Asthma Symptoms and Acute Episodes: Table 12

Quality of Life and General Health: Table 13

Summary of Results Presented in Tables 5 to 13

2.2. LUNG FUNCTION

FEV1

FVC

FEV1/FVC

FEF25-75%

PEFR

Other Lung Function Variables

Overall Conclusions for Lung Function

2.3. BRONCHIAL RESPONSIVENESS

3. SUMMARY AND CONCLUSIONS

3.1. SUMMARY

3.2. OTHER REVIEWS OF THE EVIDENCE

3.3. CONCLUSIONS

REFERENCES

ACKNOWLEDGEMENTS

INDEX.

Notes:

Description based upon print version of record.

Includes bibliographical references and index.

ISBN:

1-61728-417-3

OCLC:

923664865